KORU Medical Systems, Inc.KRMDNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank29
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P29
Within normal range
vs 5Y Ago
-0.8x
Contraction
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM-5.04%+70.1%
2024-16.86%+48.8%
2023-32.96%+9.8%
2022-36.54%-30.7%
2021-27.95%-519.5%
20206.66%-64.4%
201918.74%+37.1%
201813.67%+16.3%
201711.75%+404.7%
2016-3.86%-